IVME Historical Financial Ratios

IVME Stock  USD 0.0001  0.00  0.00%   
In Veritas is lately reporting on over 101 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Stock Based Compensation To Revenue of 0.0 or Capex To Depreciation of 7.84 will help investors to properly organize and evaluate In Veritas Medical financial condition quickly.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In Veritas Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About IVME Financial Ratios Analysis

In Veritas MedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate In Veritas investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on IVME financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across In Veritas history.

In Veritas Financial Ratios Chart

At present, In Veritas' Capex To Depreciation is projected to increase slightly based on the last few years of reporting. The current year's ROIC is expected to grow to 0.37, whereas PTB Ratio is forecasted to decline to (0.04).
Add Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueResearch And Ddevelopement To Revenue
Capex To RevenuePocfratio
Interest CoverageCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Income QualityRoe
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Current RatioReceivables Turnover
Debt To EquityRevenue Per Share
Debt To AssetsDividend Yield
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesFree Cash Flow Per Share
Average InventoryCash Per Share
Payout RatioNet Current Asset Value
Tangible Asset ValueNet Debt To E B I T D A
Tangible Book Value Per ShareGraham Number
Shareholders Equity Per ShareCapex Per Share
Graham Net NetAverage Receivables
Interest Debt Per ShareEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityDividend Payout Ratio
Enterprise Value MultipleOperating Cycle
Cash Conversion Cycle

Price To Sales Ratio

Price to Sales Ratio is figured by comparing In Veritas Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on In Veritas sales, a figure that is much harder to manipulate than other In Veritas Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Payout Ratio

Payout Ratio is the proportion of In Veritas Medical earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of In Veritas Medical dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating In Veritas Medical is paying out more in dividends than it makes in net income.
Most ratios from In Veritas' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into In Veritas Medical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In Veritas Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
At present, In Veritas' Capex To Depreciation is projected to increase slightly based on the last few years of reporting. The current year's ROIC is expected to grow to 0.37, whereas PTB Ratio is forecasted to decline to (0.04).
 2010 2011 2023 2024 (projected)
Income Quality1.960.20.230.22
Days Payables Outstanding200.2K56.8K65.3K62.0K

In Veritas fundamentals Correlations

-1.00.98-0.99-1.01.0-1.01.0-0.820.561.00.080.991.01.01.0-0.971.01.00.981.00.97-0.991.0-0.65-0.98
-1.0-0.970.991.0-1.01.0-1.00.81-0.54-1.0-0.1-0.99-1.0-1.0-1.00.96-1.0-1.0-0.99-1.0-0.970.99-1.00.660.99
0.98-0.97-0.99-0.970.98-0.970.97-0.910.630.97-0.130.940.970.990.98-1.00.960.970.930.960.89-0.990.97-0.52-0.93
-0.990.99-0.990.99-1.00.99-0.990.85-0.63-0.990.0-0.97-0.99-1.0-0.990.98-0.99-0.99-0.96-0.99-0.941.0-0.990.630.96
-1.01.0-0.970.99-1.01.0-1.00.81-0.54-1.0-0.1-0.99-1.0-1.0-1.00.96-1.0-1.0-0.99-1.0-0.970.99-1.00.660.99
1.0-1.00.98-1.0-1.0-1.01.0-0.820.561.00.070.991.01.01.0-0.971.01.00.981.00.96-0.991.0-0.65-0.98
-1.01.0-0.970.991.0-1.0-1.00.81-0.54-1.0-0.1-0.99-1.0-1.0-1.00.97-1.0-1.0-0.99-1.0-0.970.99-1.00.660.99
1.0-1.00.97-0.99-1.01.0-1.0-0.810.541.00.10.991.01.01.0-0.961.01.00.991.00.97-0.981.0-0.66-0.99
-0.820.81-0.910.850.81-0.820.81-0.81-0.51-0.810.48-0.77-0.81-0.83-0.820.94-0.79-0.81-0.74-0.79-0.670.86-0.810.120.74
0.56-0.540.63-0.63-0.540.56-0.540.54-0.510.54-0.290.420.540.590.55-0.560.520.540.410.520.41-0.660.54-0.48-0.42
1.0-1.00.97-0.99-1.01.0-1.01.0-0.810.540.10.991.01.01.0-0.961.01.00.991.00.97-0.981.0-0.66-0.99
0.08-0.1-0.130.0-0.10.07-0.10.10.48-0.290.10.190.10.040.080.160.140.10.230.140.320.040.1-0.67-0.23
0.99-0.990.94-0.97-0.990.99-0.990.99-0.770.420.990.190.990.980.99-0.940.990.991.00.990.99-0.950.99-0.66-1.0
1.0-1.00.97-0.99-1.01.0-1.01.0-0.810.541.00.10.991.01.0-0.961.01.00.991.00.97-0.981.0-0.66-0.99
1.0-1.00.99-1.0-1.01.0-1.01.0-0.830.591.00.040.981.01.0-0.970.991.00.970.990.96-0.991.0-0.64-0.97
1.0-1.00.98-0.99-1.01.0-1.01.0-0.820.551.00.080.991.01.0-0.971.01.00.981.00.97-0.991.0-0.65-0.98
-0.970.96-1.00.980.96-0.970.97-0.960.94-0.56-0.960.16-0.94-0.96-0.97-0.97-0.95-0.96-0.92-0.95-0.880.98-0.970.460.93
1.0-1.00.96-0.99-1.01.0-1.01.0-0.790.521.00.140.991.00.991.0-0.951.00.991.00.98-0.981.0-0.68-0.99
1.0-1.00.97-0.99-1.01.0-1.01.0-0.810.541.00.10.991.01.01.0-0.961.00.991.00.97-0.991.0-0.66-0.99
0.98-0.990.93-0.96-0.990.98-0.990.99-0.740.410.990.231.00.990.970.98-0.920.990.990.990.99-0.940.99-0.69-1.0
1.0-1.00.96-0.99-1.01.0-1.01.0-0.790.521.00.140.991.00.991.0-0.951.01.00.990.98-0.981.0-0.68-0.99
0.97-0.970.89-0.94-0.970.96-0.970.97-0.670.410.970.320.990.970.960.97-0.880.980.970.990.98-0.920.97-0.76-0.99
-0.990.99-0.991.00.99-0.990.99-0.980.86-0.66-0.980.04-0.95-0.98-0.99-0.990.98-0.98-0.99-0.94-0.98-0.92-0.990.620.95
1.0-1.00.97-0.99-1.01.0-1.01.0-0.810.541.00.10.991.01.01.0-0.971.01.00.991.00.97-0.99-0.66-0.99
-0.650.66-0.520.630.66-0.650.66-0.660.12-0.48-0.66-0.67-0.66-0.66-0.64-0.650.46-0.68-0.66-0.69-0.68-0.760.62-0.660.69
-0.980.99-0.930.960.99-0.980.99-0.990.74-0.42-0.99-0.23-1.0-0.99-0.97-0.980.93-0.99-0.99-1.0-0.99-0.990.95-0.990.69
Click cells to compare fundamentals

In Veritas Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether In Veritas Medical is a strong investment it is important to analyze In Veritas' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact In Veritas' future performance. For an informed investment choice regarding IVME Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In Veritas Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In Veritas. If investors know IVME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In Veritas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Return On Assets
(6.48)
The market value of In Veritas Medical is measured differently than its book value, which is the value of IVME that is recorded on the company's balance sheet. Investors also form their own opinion of In Veritas' value that differs from its market value or its book value, called intrinsic value, which is In Veritas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In Veritas' market value can be influenced by many factors that don't directly affect In Veritas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In Veritas' value and its price as these two are different measures arrived at by different means. Investors typically determine if In Veritas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In Veritas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.